“Secukinumab Treatment in Patients with Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome” (2022) Archives of Clinical and Medical Case Reports, 6(5), pp. 660–668. Available at: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22670 (Accessed: 11 September 2026).